Two pathways for venom toxin entry consequent to injection of an Australian elapid snake venom.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 06 2019
Historique:
received: 15 02 2019
accepted: 23 05 2019
entrez: 15 6 2019
pubmed: 15 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

Here we test and refute the hypothesis that venom toxins from an Australian elapid, the Eastern Brown snake (Pseudonaja textilis, PTx), solely require lymphatic transport to enter the circulation. Studies were made using anaesthetised non-recovery rats in which a marker dye (India ink) or highly potent PTx venom was injected into the hind paw. The studies required a means of inhibiting lymphatic function, as achieved by cooling of the test hind limb to low temperatures (~3 °C). Maintained entry of a non-lethal dose (0.15 mg/kg) and respiratory arrest consequent to injection of a lethal dose (1 mg/kg) of PTx venom at these low temperatures indicate that venom including toxin components enter the circulation directly via the vascular system, a process facilitated by, but not dependent on, lymphatic transport. Notably, the venom had a direct effect on vascular permeability markedly increasing this to allow extravasation of plasma albumin (MWt ~60 kDa).

Identifiants

pubmed: 31197231
doi: 10.1038/s41598-019-45022-4
pii: 10.1038/s41598-019-45022-4
pmc: PMC6565734
doi:

Substances chimiques

Albumins 0
Elapid Venoms 0
Nitric Oxide Donors 0
Ointments 0
Nitroglycerin G59M7S0WS3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8595

Références

Med J Aust. 1994 Dec 5-19;161(11-12):695-700
pubmed: 7830641
PLoS Med. 2008 Nov 4;5(11):e221
pubmed: 18986211
Lymphology. 2012 Dec;45(4):144-53
pubmed: 23700761
Wilderness Environ Med. 2005 Fall;16(3):164-7
pubmed: 16209472
Toxicon. 2015 Dec 1;107(Pt B):252-65
pubmed: 26079951
Clin Toxicol (Phila). 2011 Dec;49(10):883-5
pubmed: 22067012
Lancet. 2010 Jan 2;375(9708):77-88
pubmed: 20109866
Med J Aust. 1980 Jan 26;1(2):81
pubmed: 6767176
Wilderness Environ Med. 2009 Spring;20(1):43-56
pubmed: 19364169
PLoS Negl Trop Dis. 2015 Sep 23;9(9):e0004088
pubmed: 26398046
Nat Med. 2011 Jun 26;17(7):809-11
pubmed: 21706027
Naturwissenschaften. 1980 Aug;67(8):405-6
pubmed: 7412886
Toxins (Basel). 2014 Feb 28;6(3):850-68
pubmed: 24590383
Histochemistry. 1983;79(1):105-10
pubmed: 6196326
Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):293-5
pubmed: 7660439
PLoS One. 2013;8(4):e60625
pubmed: 23577136
J Physiol. 1965 Sep;180(2):336-49
pubmed: 5857113
Lancet. 2010 Jan 2;375(9708):89-91
pubmed: 20109867
BMJ. 2019 Jan 22;364:k5317
pubmed: 30670457
Toxicon. 2006 Jul;48(1):4-11
pubmed: 16764898
Am J Physiol. 1985 Jul;249(1 Pt 2):H174-87
pubmed: 4014482
Toxicon. 2018 Jun 15;148:123-131
pubmed: 29698755
Contrast Media Mol Imaging. 2018 Apr 22;2018:7628037
pubmed: 29849513
PLoS Negl Trop Dis. 2019 Feb 21;13(2):e0007059
pubmed: 30789906
Ann Emerg Med. 2004 Dec;44(6):599-604
pubmed: 15573035
Med J Aust. 2017 Aug 7;207(3):119-125
pubmed: 28764620
Nat Rev Dis Primers. 2017 Oct 05;3:17079
pubmed: 28980622
PLoS Negl Trop Dis. 2008;2(10):e318
pubmed: 18923712
PLoS Med. 2006 Jun;3(6):e150
pubmed: 16729843
PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1018
pubmed: 21532748
PLoS One. 2012;7(12):e53188
pubmed: 23300888
PLoS Negl Trop Dis. 2014 Feb 27;8(2):e2722
pubmed: 24587472
FEBS J. 2017 Jun;284(11):1657-1671
pubmed: 28425175
PLoS Med. 2008 Nov 4;5(11):e218
pubmed: 18986210
Clin Toxicol (Phila). 2010 Jan;48(1):61-3
pubmed: 19888893
Toxicon. 1986;24(7):730-3
pubmed: 3775789
Biochim Biophys Acta. 1993 Feb 13;1161(2-3):223-9
pubmed: 8431471
Arch Biochem Biophys. 2006 Nov 15;455(2):144-53
pubmed: 17055999
Emerg Med Australas. 2009 Jun;21(3):184-90
pubmed: 19527277
Biochem Int. 1988 Nov;17(5):825-35
pubmed: 3075905
Med J Aust. 1982 Mar 6;1(5):212-4
pubmed: 7087836
Pathology. 1981 Jan;13(1):13-27
pubmed: 7220094
Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H879-H889
pubmed: 28778912
Indian J Med Res. 1981 Feb;73:266-8
pubmed: 7239610
Nat Commun. 2016 Apr 19;7:11361
pubmed: 27093631
Toxicon. 2005 Jun 15;45(8):969-85
pubmed: 15922769

Auteurs

Dirk F van Helden (DFV)

School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia. dirk.vanhelden@newcastle.edu.au.

Peter J Dosen (PJ)

School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia.

Margaret A O'Leary (MA)

Clinical Toxicology Research Group, University of Newcastle, Callaghan, New South Wales, Australia.

Geoffrey K Isbister (GK)

Clinical Toxicology Research Group, University of Newcastle, Callaghan, New South Wales, Australia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH